[HTML][HTML] A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity

Y Wang, M Wang, K Yu, S Xu, P Qiu, Z Lyu… - Cancer Biology & …, 2023 - ncbi.nlm.nih.gov
Objective: Neoadjuvant therapy (NAT) has been widely implemented as an essential
treatment to improve therapeutic efficacy in patients with locally-advanced cancer to reduce …

Neo-peripheral adaptive immune score predicts neoadjuvant chemotherapy for locally advanced breast cancer

H Wang, X Sheng, T Yan, Y Xu, Y Wang, Y Lin… - Breast Cancer Research …, 2023 - Springer
Purpose Whether peripheral immune cell subsets can predict pathological complete
response (pCR) in breast cancer patients remains to be elucidated. We aimed to dissect the …

[HTML][HTML] Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients

J Chen, L Hao, X Qian, L Lin, Y Pan, X Han - Frontiers in Immunology, 2022 - frontiersin.org
Breast cancer (BC) is the most common malignancy worldwide and neoadjuvant therapy
(NAT) plays an important role in the treatment of patients with early BC. However, only a …

[HTML][HTML] An immune model to predict prognosis of breast cancer patients receiving neoadjuvant chemotherapy based on support vector machine

M Wang, Z Pang, Y Wang, M Cui, L Yao, S Li… - Frontiers in …, 2021 - frontiersin.org
Tumor microenvironment has been increasingly proved to be crucial during the
development of breast cancer. The theory about the conversion of cold and hot tumor …

[HTML][HTML] Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer

A Zapater-Moros, A Gámez-Pozo, G Prado-Vázquez… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Breast cancer is the most frequent tumor in women and its incidence is increasing.
Neoadjuvant chemotherapy has become standard of care as a complement to surgery in …

Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer

J Feng, J Yi, X Zouxu, J Li, Z Xiong, X Huang… - Cancer …, 2022 - Wiley Online Library
Background Host immunity plays an important role in tumor development and treatment.
Tumor‐infiltrating lymphocytes (TILs) have been proven to predict the efficacy of …

[HTML][HTML] Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer

Y Sota, Y Naoi, R Tsunashima, N Kagara, K Shimazu… - Annals of oncology, 2014 - Elsevier
Background The aim of this study was to construct a novel prediction model for the
pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) using immune …

Immune correlates of the differing pathological and therapeutic effects of neoadjuvant chemotherapy in breast cancer

R Kim, A Kawai, M Wakisaka, S Sawada… - European Journal of …, 2020 - Elsevier
Purpose To evaluate immune responses paralleling the pathological and therapeutic effects
of neoadjuvant chemotherapy (NAC) in the tumor microenvironment of breast cancer …

Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer

W Zhang, K Xu, Z Li, L Wang, H Chen - Clinical and Translational …, 2023 - Springer
Breast cancer is an epithelial malignant tumor that occurs in the terminal ducts of the breast.
Neoadjuvant chemotherapy (NACT) is an important part of breast cancer treatment. Its …

[HTML][HTML] Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers

LM Tseng, CC Huang, YF Tsai, JL Chen, TC Chao… - Translational …, 2023 - Elsevier
Neoadjuvant chemotherapy (NACT)-induced pathologic complete response (pCR) is
associated with a favorable prognosis for breast cancer. Prior research links tumor …